A Response to: Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance”
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-01-01
|
| Series: | Rheumatology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40744-024-00739-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850094940106784768 |
|---|---|
| author | Bogdan Batko Jose L. Rivas |
| author_facet | Bogdan Batko Jose L. Rivas |
| author_sort | Bogdan Batko |
| collection | DOAJ |
| format | Article |
| id | doaj-art-77daf8ea5f604379b0bada09ef99ff3f |
| institution | DOAJ |
| issn | 2198-6576 2198-6584 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Rheumatology and Therapy |
| spelling | doaj-art-77daf8ea5f604379b0bada09ef99ff3f2025-08-20T02:41:33ZengAdis, Springer HealthcareRheumatology and Therapy2198-65762198-65842025-01-0112240340510.1007/s40744-024-00739-1A Response to: Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance”Bogdan Batko0Jose L. Rivas1Faculty of Medicine and Health Sciences, Department of Rheumatology and Immunology, Andrzej Frycz Modrzewski UniversityPfizer SLUhttps://doi.org/10.1007/s40744-024-00739-1Antirheumatic agentsEfficacyNorth AmericaPolandRheumatoid arthritisSafety |
| spellingShingle | Bogdan Batko Jose L. Rivas A Response to: Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance” Rheumatology and Therapy Antirheumatic agents Efficacy North America Poland Rheumatoid arthritis Safety |
| title | A Response to: Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance” |
| title_full | A Response to: Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance” |
| title_fullStr | A Response to: Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance” |
| title_full_unstemmed | A Response to: Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance” |
| title_short | A Response to: Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance” |
| title_sort | response to letter to the editor regarding geographical differences in the safety and efficacy of tofacitinib versus tnfi a post hoc analysis of oral surveillance |
| topic | Antirheumatic agents Efficacy North America Poland Rheumatoid arthritis Safety |
| url | https://doi.org/10.1007/s40744-024-00739-1 |
| work_keys_str_mv | AT bogdanbatko aresponsetolettertotheeditorregardinggeographicaldifferencesinthesafetyandefficacyoftofacitinibversustnfiaposthocanalysisoforalsurveillance AT joselrivas aresponsetolettertotheeditorregardinggeographicaldifferencesinthesafetyandefficacyoftofacitinibversustnfiaposthocanalysisoforalsurveillance AT bogdanbatko responsetolettertotheeditorregardinggeographicaldifferencesinthesafetyandefficacyoftofacitinibversustnfiaposthocanalysisoforalsurveillance AT joselrivas responsetolettertotheeditorregardinggeographicaldifferencesinthesafetyandefficacyoftofacitinibversustnfiaposthocanalysisoforalsurveillance |